T

Tenaya Therapeutics

136 employees

Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cardiomyopathies
Gene Therapy
Cellular Regeneration
Biopharma
Heart Failure
Health Care
Precision Medicine
Cardiovascular Disease
Therapeutics
In Vivo Cellular Reprogramming
iPSC-Cardiomyoctyes

Date founded

2016

Funding rounds raised

Total raised

$106M

from 11 investors over 11 rounds

T

Tenaya Therapeutics raised $106M on March 1, 2021

Investors: Casdin Capital, LLC, RA Capital Management, L.P., GV, The Column Group, RTW Investments, LP and T. Rowe Price

T

Tenaya Therapeutics raised $92M on October 3, 2019

Investors: Greenspring Associates, Casdin Capital, LLC, GV and The Column Group

T

Tenaya Therapeutics raised $50M on December 6, 2016

Investors: The Column Group

FAQ